Clinical Trial Update: Ex Vivo Expansion (ACT-X)

View source ↗

Summary

Mayo Clinic's ACT-X ex vivo expansion therapy is in a recruiting clinical trial for solid tumors. Enrollment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Neoplasm
• Solid Tumor

Drugs mentioned

• ACT-X

Snippet

Sponsor: Mayo Clinic | Conditions: Solid Tumor, Healthy | Status: RECRUITING